Magnesium Sulfate in 5% Dextrose Injection is indicated for: Prevention of eclampsia in patients with preeclampsia, Treatment of seizures and prevention of recurrent seizures in patients with eclampsia Magnesium Sulfate in 5% Dextrose Injection is indicated for: Prevention of eclampsia in patients with preeclampsia, Treatment of seizures and prevention of recurrent seizures in patients with eclampsia.
From the U.S. FDA-approved label for Magnesium sulfate. Full label: DailyMed.
Magnesium Sulfate in 5% Dextrose Injection is indicated for: Prevention of eclampsia in patients with preeclampsia, Treatment of seizures and prevention of recurrent seizures in patients with eclampsia Magnesium Sulfate in 5% Dextrose Injection is indicated for: Prevention of eclampsia in patients with preeclampsia, Treatment of seizures and prevention of recurrent seizures in patients with eclampsia.
From the U.S. FDA-approved label for Magnesium sulfate. Full label: DailyMed.
Visually inspect Magnesium Sulfate in 5% Dextrose Injection for particulate matter and discoloration prior to administration. Do not administer unless solution is clear and colorless to slightly yellow., For intravenous use only, Administered via intravenous infusion pump Magnesium Sulfate in 5% Dextrose Injection does not require dilution prior to intravenous administration. After removing the overwrap, check for minute leaks by squeezing the container fully.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Magnesium Sulfate in 5% Dextrose Injection is contraindicated in patients: with heart block or myocardial damage, in diabetic coma, with myasthenia gravis, Heart block or myocardial damage, Diabetic coma, Myasthenia gravis
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Fetal-neonatal toxicity with prolonged use: Administration beyond 5 to 7 days is not recommended and can lead to hypocalcemia and bone abnormalities, Risk of magnesium toxicity: Monitor magnesium concentrations and clinical signs of magnesium toxicity including respiratory depression, an injectable calcium salt should be immediately available to counteract hazards, for significant toxicity stop Magnesium Sulfate in 5% Dextrose Injection, Risk of elevated blood glucose: Solutions containing dextrose should be used with caution in patients with known prediabetes or diabetes mellitus…
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions have been identified in clinical studies or postmarketing reports. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
1 product from 1 maker in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Umg 400 Tablet | Magnesium (400mg) | Uvtech Biosciences Private Limited | strip of 10 tablets |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store at 20°C to 25°C (68°F to 77°F). Protect from freezing.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
